Trial Profile
Mildronate - Efficacy And Safety Of Treatment For Chronic Coronary Heart Disease (Stable Angina) I.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Apr 2012
Price :
$35
*
At a glance
- Drugs Meldonium (Primary) ; Ischaemic heart disorder therapies
- Indications Angina pectoris; Myocardial ischaemia
- Focus Adverse reactions; Therapeutic Use
- Acronyms MILSS-I
- Sponsors Grindeks
- 16 Aug 2011 New trial record